Nizamudin, M., Kumar, M. P., Gautham, A., Sriram, D. K. and George, M. (2020) “Roflumilast: First approved oral selective PDE4 inhibitor for the treatment of COPD”, International Journal of Health and Clinical Research, 3(5), pp. 85–89. Available at: https://ijhcr.com/index.php/ijhcr/article/view/157 (Accessed: 2April2025).